Vornorexant: Difference between revisions

Vornorexant
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Newer edit →

Revision as of 11:35, 15 February 2025

An article about the drug Vornorexant

Vornorexant is a medication that acts as a dual orexin receptor antagonist. It is primarily investigated for its potential use in the treatment of insomnia and other sleep disorders.

Mechanism of Action

Vornorexant works by selectively blocking the action of orexin neuropeptides. Orexins, also known as hypocretins, are neuropeptides that regulate arousal, wakefulness, and appetite. By inhibiting the binding of orexins to their receptors, Vornorexant promotes sleep by reducing wakefulness.

Pharmacokinetics

The pharmacokinetic profile of Vornorexant includes its absorption, distribution, metabolism, and excretion. After oral administration, Vornorexant is absorbed into the bloodstream and distributed throughout the body. It is metabolized primarily in the liver and excreted via the kidneys.

Clinical Trials

Vornorexant has undergone several clinical trials to evaluate its efficacy and safety in treating insomnia. These trials assess various parameters such as sleep onset latency, total sleep time, and sleep quality.

Side Effects

Common side effects of Vornorexant may include drowsiness, headache, and dizziness. As with any medication, it is important to monitor for adverse effects and consult a healthcare provider if they occur.

Potential Uses

While primarily studied for insomnia, Vornorexant may have potential applications in other conditions related to sleep disturbances, such as narcolepsy and shift work sleep disorder.

Related pages

@@ Line 1: / Line 1: @@
-'''Vornorexant''' is a [[pharmaceutical drug]] currently under development for the treatment of [[insomnia]]. It is classified as a dual orexin receptor antagonist (DORA), which means it works by blocking the [[orexin]] neurotransmitter system in the brain. This system is known to play a key role in regulating sleep-wake cycles.
+{{Short description|An article about the drug Vornorexant}}
+{{Drugbox
+| verifiedfields = changed
+| verifiedrevid = 123456789
+| image = Vornorexant_skeletal.svg
+| image_size = 250px
+| image_alt = Skeletal structure of Vornorexant
+}}
-== Mechanism of Action ==
+'''Vornorexant''' is a medication that acts as a dual orexin receptor antagonist. It is primarily investigated for its potential use in the treatment of insomnia and other sleep disorders.
-Vornorexant, like other DORAs, works by inhibiting the action of orexin, a neurotransmitter that promotes wakefulness. By blocking the orexin receptors, Vornorexant reduces the activity of the arousal system and promotes sleep.
+==Mechanism of Action==
+Vornorexant works by selectively blocking the action of [[orexin]] neuropeptides. Orexins, also known as hypocretins, are neuropeptides that regulate arousal, wakefulness, and appetite. By inhibiting the binding of orexins to their receptors, Vornorexant promotes sleep by reducing wakefulness.
-== Clinical Trials ==
+==Pharmacokinetics==
+The pharmacokinetic profile of Vornorexant includes its absorption, distribution, metabolism, and excretion. After oral administration, Vornorexant is absorbed into the bloodstream and distributed throughout the body. It is metabolized primarily in the liver and excreted via the kidneys.
-Vornorexant has undergone several [[clinical trial]]s to assess its safety and efficacy in treating insomnia. These trials have shown promising results, with participants reporting improved sleep quality and duration. However, further research is needed to fully understand the long-term effects and potential side effects of the drug.
+==Clinical Trials==
+Vornorexant has undergone several [[clinical trial]]s to evaluate its efficacy and safety in treating insomnia. These trials assess various parameters such as sleep onset latency, total sleep time, and sleep quality.
-== Potential Side Effects ==
+==Side Effects==
+Common side effects of Vornorexant may include [[drowsiness]], [[headache]], and [[dizziness]]. As with any medication, it is important to monitor for adverse effects and consult a healthcare provider if they occur.
-As with any medication, Vornorexant may cause side effects. These can include drowsiness, dizziness, and headache. In rare cases, serious side effects such as sleepwalking or memory loss may occur. Patients should discuss potential risks with their healthcare provider before starting treatment.
+==Potential Uses==
+While primarily studied for insomnia, Vornorexant may have potential applications in other conditions related to sleep disturbances, such as [[narcolepsy]] and [[shift work sleep disorder]].
-== Future Research ==
+==Related pages==
+* [[Orexin receptor antagonist]]
+* [[Insomnia]]
+* [[Sleep disorder]]
-Future research on Vornorexant will focus on long-term safety and efficacy, as well as potential uses beyond insomnia. For example, because the orexin system is also involved in regulating appetite and energy expenditure, Vornorexant may have potential applications in the treatment of obesity or metabolic disorders.
+[[Category:Hypnotics and sedatives]]
+[[Category:Orexin receptor antagonists]]
-[[Category:Pharmaceutical Drugs]]
-[[Category:Insomnia Treatments]]
-[[Category:Clinical Trials]]
-[[Category:Neurotransmitters]]
-{{medicine-stub}}